Leerink Partnrs Predicts Lower Earnings for DENTSPLY SIRONA

Key Points

• Leerink Partners has lowered its FY2027 earnings per share estimate for DENTSPLY SIRONA from $2.34 to $2.31.
• The company reported quarterly earnings of $0.52 per share, slightly exceeding analysts' expectations of $0.50, but its revenue was down 4.9% year-over-year.
• DENTSPLY SIRONA has a current consensus rating of "Hold" among analysts, with a target price of $18.00.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Research analysts at Leerink Partnrs reduced their FY2027 earnings per share estimates for shares of DENTSPLY SIRONA in a report released on Tuesday, October 14th. Leerink Partnrs analyst M. Cherny now anticipates that the medical instruments supplier will post earnings per share of $2.31 for the year, down from their prior forecast of $2.34. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's FY2028 earnings at $2.63 EPS.

Other equities analysts also recently issued reports about the company. Weiss Ratings reissued a "sell (d-)" rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Stifel Nicolaus lowered their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. Evercore ISI cut their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an "in-line" rating on the stock in a research report on Wednesday, October 8th. Finally, Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, September 26th. Two research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $18.00.

DENTSPLY SIRONA Stock Up 2.6%

Shares of NASDAQ XRAY opened at $12.80 on Thursday. The firm has a market capitalization of $2.55 billion, a price-to-earnings ratio of -2.70, a PEG ratio of 0.78 and a beta of 0.96. DENTSPLY SIRONA has a 52-week low of $11.69 and a 52-week high of $24.86. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The stock has a 50 day moving average price of $13.41 and a 200 day moving average price of $14.55.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The business had revenue of $936.00 million for the quarter, compared to analysts' expectations of $929.67 million. During the same period last year, the firm earned $0.49 earnings per share. The business's quarterly revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Shareholders of record on Friday, September 26th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio is -13.50%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Envestnet Asset Management Inc. increased its stake in DENTSPLY SIRONA by 9.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier's stock valued at $7,391,000 after buying an additional 40,936 shares during the period. Brown Advisory Inc. acquired a new stake in shares of DENTSPLY SIRONA during the first quarter worth approximately $679,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of DENTSPLY SIRONA during the first quarter worth approximately $366,000. Krilogy Financial LLC acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth approximately $336,000. Finally, BFI Infinity Ltd. acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth approximately $335,000. 95.70% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.